XBiotech Inc. (XBIT) Stock

Healthcare · Biotechnology · Member of Other US Stocks

XBiotech Inc. (XBIT) closed at USD 2.16 on 2026-10-14, a change of -9.6 % over the past year, with a market capitalization of USD 65.85M.

XBiotech Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

XBiotech Inc. key figures

Previous close

USD 2.16 (2026-10-14)

1-year change

-9.6 %

Market cap

USD 65.85M

Enterprise value

USD -43.67M

P/E ratio (trailing)

-1.47

P/E ratio (forward)

16.62

EPS (trailing)

-1.47

EPS (forward)

0.13

PEG ratio

n/a

Price to book

0.51

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

6.30

Employees

87

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About XBiotech Inc.

XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for XBiotech Inc. and compare it with other stocks.